We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+39.65%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$2.91B
AUM Growth
+$647M
Cap. Flow
-$57.9M
Cap. Flow %
-1.99%
Top 10 Hldgs %
34.16%
Holding
142
New
8
Increased
32
Reduced
31
Closed
11

Top Buys

Rank Stock Value
1
TWLO icon
Twilio
TWLO
+$68.4M
2
XYL icon
Xylem
XYL
+$29M
3
ROP icon
Roper Technologies
ROP
+$21.6M
4
VMC icon
Vulcan Materials
VMC
+$16.1M
5
LKFT
Lakefront Biotherapeutics American Depositary Shares
LKFT
+$13.4M

Top Sells

Rank Stock Value
1
SEND
SendGrid, Inc.
SEND
+$77.4M
2
LOXO
Loxo Oncology, Inc
LOXO
+$38.4M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$36.4M
4
PANW icon
Palo Alto Networks
PANW
+$19.8M
5
SAGE
Sage Therapeutics
SAGE
+$19M

Sector Composition

Rank Sector Weight
1 Healthcare 46.61%
2 Technology 21%
3 Consumer Discretionary 9.25%
4 Industrials 6.6%
5 Communication Services 3.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FOLD
51
DELISTED
Amicus Therapeutics
FOLD
$22M 0.76%
1,615,000
+279,000
+21% +$3.41M
APTV icon
52
Aptiv
APTV
$12.4B
$21.9M 0.75%
275,000
+650
+0.2% +$49.9K
STML
53
DELISTED
Stemline Therapeutics, Inc.
STML
$20.7M 0.71%
1,609,523
+523,123
+48% +$5.91M
TECX
54
Tectonic Therapeutic
TECX
$558M
$20.5M 0.7%
77,408
– –
LKFT
55
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.83B
$20.4M 0.7%
173,000
+133,000
+333% +$13.4M
TLND
56
DELISTED
Talend S.A. American Depositary Shares
TLND
$19.6M 0.68%
388,033
– –
BOLD
57
DELISTED
Audentes Therapeutics, Inc
BOLD
$19.5M 0.67%
499,000
+224,000
+81% +$6.42M
GBT
58
DELISTED
Global Blood Therapeutics, Inc.
GBT
$19.4M 0.67%
367,000
– –
PFPT
59
DELISTED
Proofpoint, Inc.
PFPT
$19.2M 0.66%
158,000
– –
ARGX icon
60
argenx
ARGX
$55B
$19.1M 0.66%
153,000
-101,000
-40% -$11.9M
HASI icon
61
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.89B
$17.8M 0.61%
693,000
-5,000
-0.7% -$117K
WBC
62
DELISTED
WABCO HOLDINGS INC.
WBC
$17.7M 0.61%
134,000
-121,600
-48% -$15M
VKTX icon
63
Viking Therapeutics
VKTX
$3.88B
$17.5M 0.6%
1,757,000
– –
AY
64
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
$16.7M 0.57%
857,000
-9,000
-1% -$171K
GWPH
65
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$15.7M 0.54%
93,006
+29,506
+46% +$4.39M
STKL
66
DELISTED
SunOpta
STKL
$14.9M 0.51%
4,300,540
– –
STRO icon
67
Sutro Biopharma
STRO
$385M
$13.8M 0.47%
124,490
– –
MIC
68
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
$13.4M 0.46%
325,500
-210,500
-39% -$8.64M
RCKT icon
69
Rocket Pharmaceuticals
RCKT
$351M
$12.4M 0.43%
708,600
– –
OKTA icon
70
Okta
OKTA
$23.6B
$12.4M 0.43%
+150,000
New +$11.9M
EXAS
71
DELISTED
Exact Sciences
EXAS
$12.1M 0.42%
140,000
+9,000
+7% +$766K
IFRX icon
72
InflaRx
IFRX
$245M
$10.4M 0.36%
275,000
– –
ARQL
73
DELISTED
Arqule Inc
ARQL
$10.1M 0.35%
2,100,000
+1,034,000
+97% +$3.99M
MDCO
74
DELISTED
Medicines Co
MDCO
$9.36M 0.32%
335,000
– –
CRNX icon
75
Crinetics Pharmaceuticals
CRNX
$8.88B
$8.74M 0.3%
384,000
+260,775
+212% +$6.41M
1 2
3
4 5

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
WHRC
W.H. Reaves & Co Jersey City, New Jersey $6.03B AUM 40.55% 1-Year Est. Return
GA
Greenhaven Associates Purchase, New York $6.07B AUM 11.2% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Eventide Asset Management's Q1 2019 Portfolio in Review

As of Q1 2019, Eventide Asset Management held 142 positions worth $2.91B, up 29% from $2.26B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Eventide Asset Management's Q1 2019 filing shows 8 new, 32 increased, 31 reduced and 11 closed positions. Its largest new stake was Xylem: 397,000 shares worth $31.4M. The largest sale was SendGrid, Inc., an estimated $77.4M.

By sector, the portfolio is most concentrated in Healthcare at 47% of assets, up from 43% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Eventide Asset Management's largest Q1 2019 buy was Xylem: 397,000 shares worth $31.4M.
  • Eventide Asset Management added most to Twilio in Q1 2019, an estimated $68.4M increase.
  • Eventide Asset Management's biggest Q1 2019 reduction was Vertex Pharmaceuticals, cutting an estimated $36.4M.
  • Eventide Asset Management fully exited SendGrid, Inc. in Q1 2019, selling an estimated $77.4M.
  • Eventide Asset Management's ten largest holdings make up 34% of its $2.91B portfolio in Q1 2019.
  • Eventide Asset Management opened 8 new positions and closed 11 in Q1 2019.
  • Eventide Asset Management's portfolio value rose 29% quarter-over-quarter to $2.91B.

Based on Eventide Asset Management's 13F filing for Q1 2019, filed 15 May 2019.